Skip to main content
. 2017 Sep 22;10:373–384. doi: 10.2147/CCID.S141887

Table 2.

Clinical severity of individual symptoms assessed in the skin areas treated with study medication (patients with available data)

Disease symptoms Clinical Severity score
Baseline Final visit

Median (range) Median (range)
Acne vulgaris
 Erythema 3.0 (2–4) 2.0 (1–3)
 Papules 3.0 (2–5) 2.0 (1–4)
 Comedones 2.0 (1–4) 2.0 (1–3)
 Pustules 2.0 (1–4) 1.0 (1–3)
 Telangiectasia 1.0 (1–2) 1.0 (1–2)
 Seborrhoea 2.0 (1–4) 2.0 (1–3)
Atopic dermatitis
 Erythema 3.0 (2–4) 2.0 (2–4)
 Induration 3.0 (2–4) 3.0 (1–4)
 Excoriation 3.0 (2–4) 2.0 (1–4)
 Lichenification 3.0 (2–4) 3.0 (2–4)
 Exudation 2.0 (1–3) 1.0 (1–2)
 Itching 3.0 (2–4) 2.0 (1–5)
Impetigo contagiosa
 Erythema 3.4 (1–4) 2.0 (1–3)
 Pustulation 2.5 (1–5) 1.0 (1–3)
 Erosion 3.5 (2–5) 2.0 (1–4)
 Crusts 4.0 (1–5) 2.0 (1–4)
 Exudation 2.0 (2–4) 2.0 (1–3)
Rosacea
 Erythema 4.0 (1–4) 3.0 (1–3)
 Papules 3.5 (2–4) 3.0 (1–4)
 Pustules 3.0 (2–4) 1.5 (1–3)
 Telangiectasia 2.0 (1–3) 2.0 (1–2)
 Seborrhea 2.0 (2–3) 2.0 (2–2)

Notes: Clinical Severity scores were rated on a five-point numerical analog scale (1=not at all to 5= very strongly)